search
Immunis
Trends
- 1Immunis Named Semifinalist in $1.5 Million Healthy Longevity Competition▼Immunis Named Semifinalist in National Academy of Medicine’s $1.5 Million Healthy Longevity Global Competition Grand Prize
Biotech company Immunis has been named a semifinalist in the National Academy of Medicine's Healthy Longevity Global Competition, which awards a $1.5 million grand prize. The competition recognizes innovators working to extend healthy human lifespan, and Immunis advances alongside other selected candidates competing for the top award in the global longevity science field.